TY - JOUR
T1 - Functional Interactions between μ Opioid and α 2A-Adrenergic Receptors
AU - Jordan, B. A.
AU - Gomes, I.
AU - Rios, C.
AU - Filipovska, J.
AU - Devi, Lakshmi A.
PY - 2003/12
Y1 - 2003/12
N2 - Adrenergic and opioid receptors belong to the rhodopsin family of G-protein coupled receptors, couple to analogous signal transduction pathways, and affect the nociceptive system. Although a number of previous studies have reported functional interactions between these two receptors, the basis for this has not been well explored. We propose that direct receptor-receptor interactions could account, in part, for opioid-adrenergic cross-talk. In this report, we have addressed this using biophysical, biochemical, and pharmacological studies. We show that μ opioid and α2A adrenergic receptors reside in close proximity in live cells using the bioluminescence resonance energy transfer assay. These receptors colocalize to proximal dendrites in primary hippocampal neurons. μ-α2A Receptor complexes can be isolated from heterologous cells or primary neurons coexpressing these receptors. In these cells, the activation of either μ or α2A receptor leads to a significant increase in the level of immunoprecipitable μ-α2A complexes, whereas activation of both receptors leads to a significant decrease. The implications of these effects on signaling were examined using the agonist-mediated increase in G-protein activity and mitogen-activated protein kinase activity. We find that activation of either μ or α2A receptors leads to an increase in the extent of signaling, whereas activation of both receptors leads to a decrease. The increase in signaling by individual ligands and decrease by a combination of ligands is also seen in primary spinal cord neurons endogenously expressing these receptors. Taken together, these results suggest that physical associations between μ and α2A receptors could play a role in the functional interactions between these receptors.
AB - Adrenergic and opioid receptors belong to the rhodopsin family of G-protein coupled receptors, couple to analogous signal transduction pathways, and affect the nociceptive system. Although a number of previous studies have reported functional interactions between these two receptors, the basis for this has not been well explored. We propose that direct receptor-receptor interactions could account, in part, for opioid-adrenergic cross-talk. In this report, we have addressed this using biophysical, biochemical, and pharmacological studies. We show that μ opioid and α2A adrenergic receptors reside in close proximity in live cells using the bioluminescence resonance energy transfer assay. These receptors colocalize to proximal dendrites in primary hippocampal neurons. μ-α2A Receptor complexes can be isolated from heterologous cells or primary neurons coexpressing these receptors. In these cells, the activation of either μ or α2A receptor leads to a significant increase in the level of immunoprecipitable μ-α2A complexes, whereas activation of both receptors leads to a significant decrease. The implications of these effects on signaling were examined using the agonist-mediated increase in G-protein activity and mitogen-activated protein kinase activity. We find that activation of either μ or α2A receptors leads to an increase in the extent of signaling, whereas activation of both receptors leads to a decrease. The increase in signaling by individual ligands and decrease by a combination of ligands is also seen in primary spinal cord neurons endogenously expressing these receptors. Taken together, these results suggest that physical associations between μ and α2A receptors could play a role in the functional interactions between these receptors.
UR - http://www.scopus.com/inward/record.url?scp=0346996861&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0346996861&partnerID=8YFLogxK
U2 - 10.1124/mol.64.6.1317
DO - 10.1124/mol.64.6.1317
M3 - Article
C2 - 14645661
AN - SCOPUS:0346996861
SN - 0026-895X
VL - 64
SP - 1317
EP - 1324
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 6
ER -